Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis

Detalles Bibliográficos
Autores principales: Guglielmelli, P, Rotunno, G, Fanelli, T, Pacilli, A, Brogi, G, Calabresi, L, Pancrazzi, A, Vannucchi, A M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635198/
https://www.ncbi.nlm.nih.gov/pubmed/26473532
http://dx.doi.org/10.1038/bcj.2015.90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635198/
https://www.ncbi.nlm.nih.gov/pubmed/26473532
http://dx.doi.org/10.1038/bcj.2015.90

Ejemplares similares